Business Context and Reporting Period
This Form 8-K Current Report from Lipocine Inc. covers the annual general meeting of shareholders held on June 13, 2017. The company is incorporated in Delaware and operates from Salt Lake City, Utah.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Shareholders voted on two primary matters during the annual meeting:
- Election of Directors: Five nominees were elected for one-year terms. All nominees received a majority of votes cast "For."
- Ratification of Auditors: Shareholders ratified the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2017.
| Director Nominee | Votes For | Votes Withheld | Broker Non-Votes |
|---|---|---|---|
| Dr. Mahesh V. Patel | 9,069,594 | 678,150 | 7,636,144 |
| Dr. Stephen A Hill | 8,808,210 | 939,534 | 7,636,144 |
| Jeffrey A. Fink | 9,674,002 | 73,742 | 7,636,144 |
| John W. Higuchi | 7,697,674 | 2,050,070 | 7,636,144 |
| Dr. Richard Dana Ono | 8,893,861 | 853,883 | 7,636,144 |
Auditor Ratification Vote: 17,148,980 For, 84,864 Against, 150,044 Abstain.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the composition of the newly elected Board of Directors.
- Confirm the engagement of KPMG LLP for the 2017 fiscal year audit.
- Review the significant number of broker non-votes (7,636,144) recorded for the director elections to understand voting power distribution.
- Check subsequent filings for financial performance data, as this 8-K contains no financial metrics.